Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer CEO says the drugmaker is prepared to shift manufacturing to the US amid tariff threats )
Also on site :
- Trump advisor expects China trade deal conclusion Monday
- China’s Exports of Rare Earths Jump Despite Shipment Controls
- U.S. Rooftop Solar Giant Sunnova Files for Bankruptcy